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Background: VERNALIZATION1 (VRN1) binds DNA sequence nonspecifically in vitro, and its loss causes vernalization
defects in plants.
Results:Dominant suppression of VRN1 targets was lethal, and a triple mutant of the VRN1 B3 domain ablated DNA binding.
Conclusion: The DNA-interacting surface of VRN1 B3 is defined.
Significance: B3 domains are ubiquitous in plants, and learning how VRN1 B3 binds DNA is important for understanding
B3-mediated processes.
The B3 DNA-binding domain is a plant-specific domain
found throughout the plant kingdom from the alga Chlamy-
domonas to grasses and flowering plants. Over 100 B3 domain-
containing proteins are found in the model plant Arabidopsis
thaliana, and one of these is critical for accelerating flowering in
response to prolonged cold treatment, an epigenetic process
called vernalization. Despite the specific phenotype of genetic
vrn1mutants, theVERNALIZATION1 (VRN1)protein localizes
throughout the nucleus and shows sequence-nonspecific bind-
ing in vitro. In this work, we used a dominant repressor tag that
overcomes genetic redundancy to show thatVRN1 is involved in
processes beyond vernalization that are essential for Arabidop-
sis development. To understand its sequence-nonspecific bind-
ing, we crystallizedVRN1(208–341) and solved its crystal struc-
ture to 1.6 Å resolution using selenium/single-wavelength
anomalous diffraction methods. The crystallized construct
comprises the second VRN1 B3 domain and a preceding region
conserved among VRN1 orthologs but absent in other B3
domains.We established theDNA-binding face usingNMRand
then mutated positively charged residues on this surface with a
series of 16 Ala and Glu substitutions, ensuring that the protein
fold was not disturbed using heteronuclear single quantum cor-
relation NMR spectra. The triple mutant R249E/R289E/R296E
was almost completely incapable of DNAbinding in vitro. Thus,
wehave revealed that althoughVRN1 is sequence-nonspecific in
DNA binding, it has a defined DNA-binding surface.
As its name suggests, the protein VERNALIZATION1
(VRN1) was discovered for its role inArabidopsis vernalization
(1), a physiological process by which flowering accelerates in
response to prolonged cold (i.e. winter). This process is essen-
tial for many crops to flower and is a key agronomic trait. The
reason for the failure of vrn1mutants to vernalize is their inabil-
ity during this cold treatment to suppress a key regulator of
flowering, FLC (2, 3).
Although vrn1 mutants appear to have only a single pheno-
type, there are clues that VRN1 has much broader roles. For
example, VRN1 is highly expressed throughout Arabidopsis
and associateswith transcriptionally active regions of nuclei (4).
Furthermore, overexpression of VRN1 causes early flowering,
morphological defects, and inappropriate gene expression (1).
Almost two-thirds of the VRN1 protein sequence is com-
posed of two predicted B3 DNA-binding domains, named by
the discovery of the DNA binding ability of a protein region
termed B3 in the maize protein VIVIPAROUS1 (5). VRN1 also
has two putative PESTprotein turnover domains and a putative
nuclear localization sequence (Fig. 1A) (1). A region upstream
of the second B3 domain is predicted to be helical, and its C
shifts in NMR (6) agreed with this prediction. The 100-resi-
due region linking the first B3 domain to the helix before the
secondB3 domain is predicted to be unstructured (Fig. 1A), and
among the proteins most similar to VRN1, this region is the
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most poorly conserved in sequence (Fig. 1B and supplemental
Fig. S1).
B3 domains are found throughout the plant kingdom and
have been classified into four families (ARF, RAV, LAV, and
REM) that bind the DNA sequences TGTCTC (ARF), CAC-
CTG (RAV), andCATGCA (LAV) in vitro (7). VRN1 is the only
member of the REMB3domain-containing protein class whose
DNAbinding has been studied, and it exhibits strong sequence-
nonspecific DNA binding in vitro (1).
Arabidopsis encodes over 100 B3 domain-containing pro-
teins that are implicated by genetics in processes as diverse as
seed development, drought tolerance, hormone response, and
flowering time (7). Most are thought to be sequence-specific
DNA-binding proteins with cis-elements characteristic for
each B3 class.
Here, we structurally and functionally characterize VRN1,
presenting chimeric VRN1 repressor data that strongly support
a broader role for VRN1 in processes essential to Arabidopsis
development. This highlights the fundamental importance of
VRN1 in plant development. We generated recombinant pro-
tein from a construct of VRN1 comprising residues 208–341
(VRN1(208–341), representing one of the twoB3domains) and
show that like the full-length protein, this single B3 domain
displays sequence-nonspecific DNA binding properties. We
determined a high resolution crystal structure for VRN1(208–
341) and compared it with the NMR structures of two B3
domain proteins that have not been assigned in planta func-
tions: RAV1 is a sequence-specific DNA-binding protein (8, 9),
whereas At1g16640 is reported not to bind DNA (10).We used
NMR to identify putative DNA-binding sites, which we tested
with a series of 16 mutations in VRN1(208–341) that included
a tripleArg-to-Glu change that abolished in vitroDNA-binding
activity. These data suggestedwhich residuesweremost impor-
tant but also showed that the VRN1(208–341) DNA-binding
surface was large.
EXPERIMENTAL PROCEDURES
Dominant Suppression of in Vivo VRN1 Targets—The VRN1
(At3g18990) ORF was amplified using sense and antisense
primers (5-GAT GCC ACG CCC TTT CTT CCA TAA GTT
GAT-3 and 5-GAT GCC ACG CCC TTT CTT CCA TAA
GTTGAT-3) and ligated into the SmaI site of the p35SSRDXG
vector to produce a chimeric repressor gene fused with the
SRDX repression domain (GLDLDLELRLGFA), and the region
corresponding to each transgene was transferred into the
pBCKH plant expression vector using the Gateway system
(Invitrogen) (11). C-terminal placement of the SRDX tag was
ideal, as VRN1 retains its native function with C-terminal
fusions to the much larger GFP (4). The binary construct was
transferred to Agrobacterium tumefaciens by electroporation
and transformed intowild-type ColumbiaA. thaliana plants by
floral dip (12). T1 transgenic plants were selected onMurashige
and Skoog medium-agar plates containing 3% sucrose and 30
g/ml hygromycin. Subsequently, T0/T1 seedswere sownwith-
out the pressure of hygromycin selection and screened for small
deformed plants.
VRN1(208–341) Expression, Purification, and Selenomethio-
nine Labeling—Native VRN1(208–341) protein was produced
for crystallization as described previously (13). To produce sel-
enomethionine (SeMet)4-labeled protein, Escherichia coli cells
containing a pQE30-VRN1(208–341) construct (13) were
grown in minimal M63 medium containing seleno-DL-methio-
nine (SigmaS3875) and standard amino acids before expression
was induced by isopropyl -D-thiogalactopyranoside as
described previously (14). SeMet-VRN1(208–341)was purified
and concentrated for crystallization as described (13).
VRN1(208–341) Crystal Structure Determination—Native
VRN1(208–341)was crystallized at 4 °Cusing the hanging drop
vapor diffusion method (13). SeMet-labeled protein was crys-
tallized under similar conditions using a protein concentration
of 19mg/ml and 0.1MMES (pH6.0), 1.4 M sodiumchloride, and
10 mM manganese chloride as the well solution. Crystals of
SeMet-VRN1(208–341) appeared after 20 days, whereas native
crystals formed in 6 days. Crystals of SeMet-VRN1(208–341)
grew to a maximum size of200 50 50 m.
Crystals were harvested by transferring them into a solution
containing 0.1 M MES (pH 6.0), 2 M sodium chloride, 10 mM
manganese chloride, and 20% (v/v) ethylene glycol as a cryo-
preservative. Crystals were then flash-cooled in liquid nitrogen
and stored under liquid nitrogen. These were transferred to a
dry shipper for transport to the Australian Synchrotron, where
diffraction data were measured on beamline MX1 at 0.956 Å
4 The abbreviationsusedare: SeMet, selenomethionine;HSQC, heteronuclear
single quantumcorrelation; FP, fluorescencepolarization; FAM, 6-carboxy-
fluorescein; r.m.s.d., root mean square deviation.
FIGURE 1.Schematic ofVRN1.A, VRN1 consists of twoB3domains of100 residues each. Between themare twoputative PEST-rich protein turnover domains
andaLys-richnuclear localization sequence (NLS). BelowVRN1 (fromtop tobottom) are theoutputs fromsecondary structurepredictionprograms jalign, jfreq,
jhmm, jnet, jpssm, and jpred,which suggest that only theB3domains anda regionprecedingB3bare structured. TheVRN1(208–341) protein hasbeen studied
in solution by NMR, and the C shift data (6) correlated well with these predictions. The secondary structural elements are numbered for later reference. B,
summary of the percentage conservationwithin an alignment of VRN1 and its 10most similar proteins from theGenBankTMData Bank. Conservation is high at
the B3 domains but also in the region preceding B3b. For the full sequence alignment this panel was based on, see supplemental Fig. S1.
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(15). A single-wavelength anomalous diffraction data set was
measured from the SeMet-VRN1(208–341) crystal, and a high
resolution native data set was measured from the native
VRN1(208–341) crystal. Crystals of VRN1(208–341) contain
two molecules in the crystallographic asymmetric unit.
Data were indexed, integrated, and scaled using HKL2000
(16). Heavy atom positions were identified using ShelxD (17).
Phasing was performed with PHENIX Autosol, and PHENIX
Autobuild (18) was used to generate an initial model (R 
22.9%/Rfree  27.8%) This was further refined with rounds of
manualmodel building inCoot (19) and refinement in PHENIX
Refine (20). Of the 133 residues in the designed construct, 117
residues were modeled in each of the two molecules in the
asymmetric unit. In both molecules, residues 208–220 and
339–341 of VRN1(208–341) were not modeled due to poor
electron density at the N and C termini, indicating disorder.
Four chloride ionswere included in themodel at crystal contact
points where water molecules were not sufficient to explain the
electron density.
Cross-validation Rfree calculation was performed with 5% of
the data. The quality of the model was monitored throughout
refinement using MolProbity (21). Data collection and refine-
ment statistics are given in Table 1. Raw data images will be
made available on the Diffraction IMage Experiment Reposi-
tory (DIMER) website.
B3a Modeling by I-TASSER—To generate a model structure
for B3a using the VRN1(208–341) structure, we entered the
first 104 amino acids of VRN1 (Met-1–Asn-104) into
I-TASSER (22) and, as a restraint, uploaded the Protein Data
Bank file for VRN1(208–341) in “specify template without
alignment” with otherwise default parameters used.
NMR Titration Experiments with VRN1(208–341) and
dsDNA—15N-Labeled VRN1(208–341) was produced as
described (6), and after size exclusion, its final concentration
was 0.74 mg/ml (43.6 M). An 18-bp fragment of DNA was
made by heating a mixture of 0.25 ml of 1 mM ssDNA oligonu-
cleotide JM121 (5-AAA AAT TGC ATG TCA TTC-3) and
0.25 ml of 1 mM ssDNA oligonucleotide JM122 (5-GAA TGA
CAT GCA ATT TTT-3) to 95 °C (368 K) for 5 min and allow-
ing the solution to cool to room temperature (294 K). This
18-bp region corresponds to a specific region of FLC where
VRN1 was suspected to bind in vivo, but the short repeating
AGTC probes we later used in fluorescence polarization and
the previously demonstrated sequence nonspecificity of VRN1
would suggest that any DNA sequence would give a similar
result in NMR DNA binding experiments.
The 18-bp fragment of DNA was purified by size exclusion
chromatography using a Sephacryl S75 column (GE Health-
care) in 50mM sodiumphosphate (pH 7.0), 150mMNaCl, and 1
mM DTT. After size exclusion, the concentration of the DNA
was 0.46 mg/ml (42 M).
To avoid precipitation when combining the 18-bpDNAwith
15N-labeledVRN1(208–341), we found it necessary to combine
them diluted and concentrate them after they were combined.
Each NMR DNA binding experiment began by layering in an
Amicon Ultra-4 concentrator with a 5-kDa cutoff (Millipore
UFC800524) the following solutions: 1.85 ml of 38 M 15N-
labeled VRN1(208–341), a separating “cushion” of 2 ml of size
exclusion buffer (50 mM sodium phosphate (pH 7.0), 150 mM
sodium chloride, and 1 mM DDT), and either 0.1 or 0.2 M eq of
42 M DNA. A no-DNA control containing only 15N-labeled
VRN1(208–341) was also prepared. The mixture was concen-
trated to 0.5ml (0.14mMVRN1(208–341)) before 50l of D2O
was added, and a heteronuclear single quantum correlation
(HSQC) spectrum was acquired as described (6). With 0.2 M eq
of DNA added, the number of scans was increased to 96 to
obtain similar peak resolution (64 scans were performed for the
no-DNA control and when 0.1 M eq of DNA had been added).
VRN1(208–341) Mutagenesis—Mutations were introduced
into the pQE30-VRN1(208–341) construct (13) by PCR with
complementary primer pairs. For brevity, the mutation will be
followed only by the forward primer sequence with the muta-
genic codon underlined: R249A, 5-C AGA GTG GTT CTG
GCGCCATCCTATCTATAC-3; Y254A, 5-CCATCCTAT
CTA GCG AGA GGT TGC ATC ATG-3; Y260A, 5-GGT
TGC ATC ATG GCG CTT CCT TCT GGG-3; R289A,
5-CAA TGG CCT GTT GCG TGT CTC TAC AAA GCC-3;
L291A, 5-CCT GTT CGA TGT GCG TAC AAA GCC GGG-
3; and R296A, 5-CTCTACAAAGCCGGGGCGGCCAAA
TTC AGT C-3. VRN1(208–341) mutants were 15N-labeled
during expression and purified as described (6) and concen-
trated to 0.3 mM. A two-dimensional 1H-15N HSQC spec-
trum was acquired for each mutant to ascertain the effect of
eachmutation on the protein. Subsequent to these sixmutants,
another group of six mutants were made with less conservative
changes, includingG295E (5-CTCTACAAAGCCGAGAGA
GCC AAA TTC-3), R289E (5-CAA TGG CCT GTT GAG
TGTCTCTACAAA-3), andR296E (5-TACAAAGCCGGG
GAG GCC AAA TTC AGT-3. To make the R289E/R296E
double mutant, the single mutations were introduced sequen-
tially. To make the R289A/R296A double mutant, the afore-
mentioned R289A plasmid was mutagenized by PCR with a
shorter primer for R296A (5-TACAAAGCCGGGGCGGCC
AAA TTC AGT-3). To replace the loop of VRN1 with the
sequence RPSYLYRGCI with the equivalent At1g16640-de-
rived loop sequence ISEKSSKS, PCR was done using phospho-
rylated primers JM563 (5-tct agt aaa tcc ATG TAT CTT CCT
TCT GGG-3) and JM564 (5-ttt ctc aga gat CAG AAC CAC
TCTGAAGAA-3). The bases encoding ISEKSSKS are shown
in lowercase letters and underlined. The PCR product was
ligated to create the mutant referred to hereafter as loop. A
final set of four mutants were made by incorporating R249E as
a single, second, or third mutation with the appropriate tem-
plate using primer JM577 (5-AGAGTGGTTCTGGAGCCA
TCCTATCTA-3) and its complement. All proteins were 15N-
labeled, and an HSQC spectrum was acquired for each as pre-
viously described (6).
Fluorescence Polarization DNA Binding Assay—The afore-
mentioned mutants and wild-type VRN1(208–341) were
assayed for in vitro DNA-binding activity using a fluorescence
polarization (FP) assay that measured fluorescence upon bind-
ing of each protein to 6-carboxyfluorescein (FAM)-labeled
dsDNA probes. The dsDNA probes were made by combining
JM565 (FAM-AGT CAG TCA GTC AGT-3) with JM566
(FAM-ACT GAC TGA CTG ACT-3) to a final concentration
of 0.5 M in water, placing them in boiling water for 5 min, and
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allowing the solution to cool at room temperature. An unla-
beled probe for competition was made in a similar way using
JM569 (5-AGTCAGTCAGTCAGT-3) and JM570 (5-ACT
GACTGACTGACT-3) diluted to 50M in water. The FAM-
labeled dsDNA probe was then diluted to 25 nM with FP buffer
(30mMHEPES, 50mMpotassium chloride, 10mMguanidinium
chloride, 2 mM magnesium chloride, 0.5 mM EDTA, and 0.01%
Nonidet P-40 (pH 7.5)). The protein concentration was quan-
tified using A280 (NanoDrop), and purity was confirmed by
SDS-PAGE. All FP assays were conducted in FP buffer.
The 16 mutant proteins were separated into four independ-
ent sets of experiments, each including the wild-type protein as
a control. For binding reactions, 20 l of 25 nM labeled probe
was added to 80 l of protein in FP buffer. The final protein
concentrations were 1.5, 3, 5, 10, 20, 30, 50, 75, 100, 150, 300,
and 600 nM, and the final probe concentration was 5 nM. Three
25-l aliquots of each reaction mixture were transferred to a
black opaque 384-well plate and incubated for 30 min at room
temperature in the dark beforemeasurement. FPwasmeasured
with a PerkinElmer EnVision multi-label plate reader (485 nm
excitation and 520 nm emission). A saturation binding curve
was fitted using GraphPad Prism, and the Kd value of each
mutant was determined with an average Bmax of 125 nM found
for the wild-type protein. To demonstrate that fluorescence
was probe-specific, 2.5 l of 50 M unlabeled probe (1000-fold
over the labeled probe) was added to those wells containing the
highest concentration of labeled probe, and FP was re-assayed
to demonstrate competitive displacement of the labeled probe.
RESULTS
Constitutively Expressed VRN1-SRDX Is Lethal—Arabidop-
sis vrn1 mutants have only one phenotype: their reduced ver-
nalization response (1). This specificity seems at odds with the
abundance of VRN1 and its mRNA expression in all plant tis-
sues except pollen (4). A fully functional VRN1-GFP fusion
associates throughout the nucleus (4). Furthermore, VRN1
overexpression causes accelerated flowering and pleiotropic
phenotypes (1). These features suggest that VRN1 has more
widespread roles in maintaining gene expression.
We tested the hypothesis that VRN1 function is protected by
redundancy with chimeric repressor silencing technology (23).
This approach arose from the observation that the essential
repression domain of class II ERF (ethylene-responsive ele-
ment-binding factor) transcription factors and of several
TFIIIA-type zinc-finger transcription factors is located at the C
terminus of these proteins, in a conserved sequence termed the
EAR (ERF-associated amphiphilic repression) motif. When the
EAR-like motif from SUPERMAN designated as “SRDX” was
fused to DNA-binding proteins, the chimeras acted as strong
repressors (24, 25). Constitutive expression of SRDX fusions
has been heavily used in Arabidopsis to overcome genetic
redundancy. The ability of the SRDX repression domain to
overcome genetic redundancy has been demonstrated for a
number of transcription factors, where eachmimics the pheno-
types of loss-of-function genetic mutations for the same tran-
scription factor (26), e.g. 35S:AP3:SRDX and 35S:CUC1:SRDX
(27). Thus, a VRN1-SRDX fusion is likely to act as a dominant
repressor wherever VRN1 binds in planta, even at locations
where other proteins share its roles.
We initially failed to isolate transformants containing the
35S:VRN1:SRDX construct (Fig. 2A) when the seeds of trans-
formed plants were sown on Murashige and Skoog medium-
agar containing hygromycin selection, probably due to lethality
or a severe defect in growth or development. We then grew the
T0/T1 seeds on Murashige and Skoog medium-agar without
hygromycin but supplemented with glucose and found three
small plants with the same deformed phenotype (Fig. 2, B and
C). These deformed plants developed roots and true leaves but
died before they could set seed. These three deformed plants
along with 12 aphenotypic plants were tested by PCR with 35S
and nos orVRN1 primers to show that the pleiotropy correlated
with the VRN1 transgene (Fig. 2D). Sequencing the 35S/nos
PCR product from these three lines confirmed that each con-
tained a proper VRN1-SRDX fusion. Our results suggest that
VRN1 regulates essential developmental processes in addition
to regulating vernalization. We suspect that genetic redun-
dancy is masking the role of VRN1 in essential developmental
processes.
A Structured and Conserved Region in VRN1 Orthologs—We
next investigated the structure of VRN1 to gain insight into its
function at a molecular level. Secondary structure analysis of
VRN1 suggested that it consists of two predicted B3 domains,
FIGURE 2. Phenotype of VRN1-SRDX fusion lines. A, the VRN1-SRDX con-
structs consist of the constitutive CaMV35S promoter (p35S), a VRN1ORF and
SRDX fusion, and thenopaline synthase (nos) terminator.B,magnified images
of three T1 VRN1-SRDX transgenic plants grown on glucose-containing
medium without hygromycin selection showing their small size and
deformed phenotype. C, the same three T1 plants next to non-transgenic
neighboring plants. D, results from PCR analysis of genomic DNA extracted
from transgenic and non-transgenic lines showing that the deformed plants
contain theVRN1-SRDX transgene. The smallerVRN1band corresponds to the
non-intronic VRN1 ORF used in the VRN1-SRDX transgene.
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B3a and B3b, separated by an unstructured region of100 res-
idues (Fig. 1A). A region of20 residues preceding B3b is also
predicted to be helical. An alignment of the 10 proteinswith the
highest sequence similarity to VRN1 showed that this region
preceding the second B3 domain is conserved (Fig. 1B and sup-
plemental Fig. S1). The predictions showed good correlation
with the secondary structure of VRN1(208–341) determined
experimentally from the C chemical shift data acquired by
solution NMR (Fig. 1A) (6).
VRN1(208–341) Adopts a -Barrel Fold—The crystal struc-
ture of VRN1(208–341) was solved by single-wavelength
anomalous diffraction methods and refined to high resolution
with excellent geometry (Table 1). The structure of the B3
domain of VRN1(208–341) reveals a seven-stranded -barrel
capped at either edge of the barrel by a short helix. As indicated
above, the VRN1 B3b domain is preceded by a sequence of 35
residues conserved among VRN1 orthologs. The crystal struc-
ture shows that this sequence forms a long helix (N) (Fig. 3A),
as predicted by bioinformatics (Fig. 1A) and NMR secondary
structure studies (6).
The two molecules of VRN1(208–341) in the asymmetric
unit are essentially identical (0.6 Å root mean square deviation
(r.m.s.d.) for all 117 C atoms). A loop region comprising Arg-
324–Val-329, which we refer to as the 320s loop, was predicted
to exhibit conformational exchange based on an inability to
assign Arg-324–Val-329 using NMR (6). In the crystal struc-
ture reported here, the main chain of this loop is well ordered
and adopts similar structures in both molecules, though the
side chains of Arg-324 and Arg-326 are disordered (Fig. 3B).
Comparison of VRN1 Structure with RAV1 and At1g16640—
VRN1(208–341) is the first crystal structure of a B3 domain
protein, althoughNMR structures of two plant B3 domain pro-
teins, RAV1 (ProteinData Bank code 1WID) (9) andAt1g16640
(code 1YEL) (10), have been reported previously. These three
proteins share very low sequence identity (21–27%) yet have
similar architectures, differing only in the addition of the pre-
ceding N-terminal helix in VRN1(208–341) (Fig. 4). Indeed, a
DALI search (28) found RAV1 and At1g16640 structures to be
the top hits when VRN1(208–341) was used as a search model:
At1g16640 gives a Z-score of 12.6, with 21% sequence identity
and a r.m.s.d. of 1.8 Å for 94 C atoms, and RAV1 gives a
Z-score of 9.6, with 23% sequence identity and a r.m.s.d. of 2.6Å
for 98C atoms. By comparison, DALI similarity analysis of the
At1g16640 and RAV1 structures gives a Z-score of 10.1, with
27% sequence identity and a r.m.s.d. of 2.8 Å for 94 C atoms.
Thus, of the three pairs of structures, VRN1(208–341) and
At1g16640 are the most similar to each other using DALI for
comparison. This structural similarity is reflected to some
degree in the function of these three proteins. RAV1 binds a
specific DNA sequence (8), VRN1 binds DNA sequence non-
specifically, andAt1g16640 has been reported to not bindDNA
(10).
How canwe rationalize the in vitro nonspecific DNAbinding
of VRN1(208–341) and the lack ofDNAbinding inAt1g16640?
Comparison of the structures and sequences of VRN1(208–
341) andAt1g16640 revealed several features in the former that
could contribute to DNA binding and that are absent in the
latter. Thus, VRN1(208–341) is a more basic protein overall,
with 17 basic residues and 12 acidic residues, whereas
At1g16640 has an equal number of basic and acidic residues (14
each). Furthermore, the stretch of residues encompassing
TABLE 1
Data collection, phasing, and refinement statistics
Values in parentheses are for the top shell of data.
Native
VRN1(208–341)
SeMet
VRN1(208–341)
Data collection
Wavelength (Å) 0.956 0.956
Space group C2 C2
Cell parameters
a, b, and c (Å) 106.2, 47.3, 61.4 105.9, 47.9, 61.3,
, ,  90.0°, 115.0°, 90.0° 90.0°, 114.5°, 90.0°
Resolution range (Å) 50.0–1.6 (1.66–1.6) 31.3–2.7 (2.8–2.7)
No. of observations 139,720 114,844
No. of unique reflections 34,680 (3439) 7689 (766)
Multiplicity 4.0 (4.0) 14.9 (15.2)
Completeness (%) 94.6 (93.7) 99.0 (98.6)
I/I 23 (4.6) 23.8 (21.5)
Rmerge (%) 5.3 (29.8) 8.8 (15.9)
Phasing
Resolution range (Å) 31.3–2.7
No. of selenium
atoms/asymmetric unit
2
Figure of merit (before/after
density modification)
0.32/0.72
Refinement
Resolution range (Å) 23.65–1.60 (1.65–1.60)
No. of reflections 34,661
R-factor 0.120 (0.142)
Free R-factor 0.166 (0.234)
No. of atoms
Protein 1962
Chloride ion 4
Water 366
Wilson B-factor 14
Average B-values (Å2)
Protein 19
Chloride ion 19
Water 34
r.m.s.d. in ideal
Bond lengths (Å) 0.011
Bond angles 1.3o
Ramachandran plot (%)
Favored 98.3
Outliers 0.0
MolProbity score 0.68, 100th percentile
FIGURE 3. Crystal structure of VRN1(208–341). A, structural model of
VRN1(208–341) showing that its overall fold is a barrel of -strands (yellow)
cappedat eachendby short-helices (red). The320s loop,whichcouldnotbe
assigned by NMR (potentially due to flexibility), is shown in purple. The con-
served N-terminal sequence of VRN1 proteins that is absent in other B3
domains forms a long -helix (-N, bottom right of the structure). B, the loop
region Glu-321–Val-329 showing 2Fo Fc electron density contoured at the
1 level. Images were created in PyMOL (33).
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strands 4 and 5 and the beginning of helix 2 forms a contiguous
surface on all three proteins. In RAV1, this region contributes
the DNA-binding loop 5 and in total has four basic and no
acidic residues. By comparison, this region of VRN1(208–341)
lacks the DNA-binding residues of RAV1 but does comprise
five basic residues and no acidic residues.
The electrostatic surface representations of the three B3
domains support these observations (Fig. 5). Trp-245, Asn-246,
Ser-247, and Gln-249 of RAV1 are located in a region that sep-
arates two highly basic regions; these residues are proposed to
interact directly with DNA bases (9). In both VRN1 and
At1g16640, these residues are absent: in VRN1, this region is
replaced by a broad continuous basic groove, whereas in
At1g16640, a less expansive basic groove is apparent. In
At1g16640, Glu-23 is located in themiddle of this basic groove,
although this is not apparent in the electrostatic surface.
Finally, the greater overall basicity of RAV1 and VRN1 com-
pared with At1g16640 is evident in the electrostatic surfaces.
We investigated the structures further to identify features
that might contribute to the sequence-nonspecific DNA bind-
ing properties of VRN1(208–341). The largest differences
between the B3 domains of VRN1(208–341) and RAV1 are
localized to the loop regions that join the strands of the -bar-
rel. In general, the loops of RAV1 are longer than those of
VRN1(208–341) and At1g16640 (Fig. 5). Thus, of the seven
loops in the B3 fold, three of the VRN1(208–341) loops are
shorter than those of RAV1 (by seven, two, and one residues).
For At1g16640, four loops are shorter than those of RAV1 (by
seven, two, two, and two residues).
Three of the seven RAV1 loops incorporate its DNA-binding
residues (Lys-199 and Leu-200 in loop 1; Lys-207 in loop 2; and
Trp-245, Asn-246, Ser-247, and Gln-249 in loop 5) (9), but
these residues are generally not conserved in VRN1(208–341)
or in At1g16640, and two of the DNA-binding residues in loop
5 are deleted in both VRN1(208–341) and At1g16640. These
mutations and deletionsmay explain why VRN1(208–341) and
At1g16640 do not exhibit the same DNA binding specificity of
RAV1.
Model for the First B3 Domain of VRN1—There are two B3
domains in VRN1, B3a and B3b (Fig. 1), and both bind DNA
(Ref. 1 and this work) and share a sequence identity of 18%.
Here, we have focused on the structure and DNA-binding sur-
face of B3b. Although 18% sequence identitymay be considered
low, the structural similarity of B3 domains despite similarly
low sequence identity (Fig. 4) suggests that these two domains
may share a similar fold. The notable lack in B3a of the N-ter-
minal helix in VRN1(208–341) is because this region is not part
of any B3 domain; rather, it is a specific and conserved region
found to precede the second B3 domain of plant homologs of
VRN1.
Like B3b, B3a is a highly basic domain (15 Arg/Lys residues
and 11 Asp/Glu residues) consistent with DNA binding. We
generated a homology model of B3a from the crystal structure
of B3b and found that the modeled B3a structure overlaid well
FIGURE 4.Structural superimposition and structure-based sequence alignment.A, the structures of VRN1(208–341) (cyan), At1g16640 (orange), and RAV1
(yellow) were alignedwith SSM in Coot. The resulting structural superimposition is shown in stereo. B, the structure-based sequence alignment of these three
proteins (same color scheme as in A) shows structurally aligned residues in uppercase letters. Residues that are conserved in all three structures are shown by
asterisks, and residues that are highly conserved are shown by hash symbols. Secondary structure elements in the VRN1(208–341) structure are indicated by h
for helix and s for strand. At1g, At1g16640.
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with B3b (r.m.s.d. of 1.3 Å) (supplemental Fig. S2) as well as the
B3 domains of At1g16640 (r.m.s.d. of 1.8 Å) and RAV1 (r.m.s.d.
of 2.5 Å). The B3a model also has a basic patch in a similar
location as B3b, suggesting that the same surface may bind
DNA. B3a is known to bind DNA in vitro (1), but further work
is required to confirm that the binding faces are similarly
located for both B3 domains and to establish whether the two
domains bind DNA simultaneously in vivo and, if so, where
along the DNA strand each binds.
Comparison with Bacterial Restriction Endonucleases—The
next five highest hits in theDALI analysis are for three proteins:
EcoRII (Protein Data Bank code 1NA6, chains A and B) (29),
EcoRII (code 3HQF) (30), and BfiI (code 2C1L, chains A and B)
(31), giving Z-scores ranging from 6.3 and 6.9, with sequence
identities between 10 and 16% and r.m.s.d. between 2.6 and 3.1
Å for 93–96 C atoms. All three proteins are restriction endo-
nucleases in which a DNA-binding effector domain contains a
fold very similar to that found in the B3 family (9).
Identification of the VRN1 DNA-binding Surface—Previous
work used HSQCNMRwith the RAV1 B3 domain and DNA to
predict the binding surface and propose a model for the com-
plex (9). We monitored the VRN1(208–341) HSQC spectra
after the addition of an 18-bp dsDNAprobe. In almost all cases,
the peaks corresponding to the responsive residues broadened
and disappeared. Mapping these onto the structure showed
that the binding residues could be mapped to one face of
VRN1(208–341) (Fig. 6A and supplemental Fig. S3). These data
were consistent with the electrostatic surface most favorable
for VRN1(208–341)-DNA binding and the DNA-binding sur-
face previously identified for the RAV1 B3 domain (9).
To confirm the VRN1(208–341) DNA-binding surface and
to identify the most important regions, we produced protein
mutants and assessed their in vitro DNA-binding activities
using FP assays (Fig. 6B andTable 2).We usedHSQC spectra to
ensure that the fold of each protein was maintained (supple-
mental Figs. S4–S6). Initially, we created a series of six single
Ala mutants targeting Tyr and Arg residues, but these changes
had weak or no effect on DNA binding. The most severe were
R249A and R296A, which decreased binding with a 4-fold
change in Kd. We then made a second series of six mutants,
including an R289A/R296A double mutant, a loop swap from
At1g16640, three single Glu mutants, and an R289E/R296E
double mutant. The single Glu changes R249E and R296E had
the greatest effect (8- and 12-fold change in Kd). The effect on
the binding strength of these single Glu mutations was similar
to that of the R289A/R296A double mutant. The R289E/R296E
double mutant showed a dramatic (50-fold) change in DNA
binding Kd. We then created a third round of four mutants in
which the R249E mutation was introduced singly or added to
existing single or double Glu mutations. The R249E/R289E/
R296E triplemutation almost completely abolishedDNAbind-
ing (Table 2).
Of the singlemutations, the R296E substitution had themost
deleterious effect on DNA binding, closely followed by R249E.
Although R296E and R249E most strongly affected DNA bind-
ing, all three doubleGlumutants had similar decreases inDNA-
binding activity (52–59-fold change in Kd). The DNA binding
of the triple mutant R249E/R289E/R296E was similar to that of
the negative control, suggesting that DNA binding was com-
pletely abrogated. The fact that threemutations are required to
abolish DNA binding suggests that the nonspecific DNA-bind-
ing surface of the VRN1 B3b domain is large or that there is
redundancy in the DNA-binding residues.
Model of DNA Binding by the B3 Domain of VRN1—We gen-
erated a model for DNA binding by VRN1(208–341) by super-
imposing the VRN1(208–341) structure onto the EcoRII-DNA
complex from Protein Data Bank code 3HQF (30) (Fig. 6C)
using SSM inCoot (19). TheDNAappears to fit within a groove
of VRN1(208–341), and the phosphate backbone appears to be
well placed to make contact with basic patches on the VRN1
surface.
DISCUSSION
Arabidopsis vrn1 mutants have only one phenotype: their
reduced vernalization response (1). This specificity seems at
odds with VRN1 abundance and mRNA expression in all plant
tissues except pollen (4). A fully functional VRN1-GFP fusion
associates throughout the nucleus (4). VRN1 overexpression
also causes accelerated flowering and pleiotropic phenotypes
(1). These features suggest that VRN1 has more widespread
FIGURE 5. Structural alignment of VRN1, At1g16640, and RAV1 B3
domains. A, structural alignment showing the putative DNA-binding surface
of VRN1(208–341) and RAV1. B, electrostatic surfaces of the three domains in
the same orientation as in A. Arg residues contributing to the conspicuous
basic patch on VRN1(208–341) (R249, R289, and R296) are labeled. C, electro-
static surfaces of the three domains rotated 180° around the vertical axis
relative to the surface in B. The structures were first aligned with SSM in Coot
and then oriented to show the putativeDNA-binding region of RAV1 (9), with
the surface charge ranging from3 to 3 kbT/ec(J/C), where k is the Boltzmann
constant (1.380 1023 J/K), T is in Kelvin, and e is the charge on an electron
(1.6 1019 C).
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roles than just FLC regulation. Our finding that the expression
of a 35S:VRN1:SRDX construct induced pleiotropic phenotypes
and was eventually lethal is the first experimental evidence that
VRN1 has roles that are essential to development but that are
protected by genetic redundancy. The 35S:VRN1:SRDX con-
struct did not induce embryo lethality in transgenic plants,
which were still able to develop leaves and roots, albeit
deformed. This finding indicates that despite the vernalization-
and FLC-specific phenotype of vrn1 geneticmutants, VRN1has
more widespread roles in essential processes that remain to be
revealed.
VRN1 has been shown to bind strongly to DNA but in a
sequence-nonspecificmanner (1).NMRanalysis and its pattern
of surface charge suggest that VRN1(208–341) has a definite
DNA-binding surface. We therefore compared its structure
with those of related proteins with known DNA-binding
modes.
The structural similarity between bacterial endonucleases
and B3 domain proteins has been noted previously (9) and led
to the suggestion that the B3 domain-containing plant proteins
may have evolved from a bacterial endonuclease (32). Compar-
ison of the N-terminal domain from E. coli restriction endonu-
clease EcoRII (designated as EcoRII-N) withArabidopsisRAV1
and At1g16640 B3 domains led Golovenko et al. (30) to claim
that the structure of EcoRII-N in complex with DNA was the
first structure of a B3 family proteinwithDNA. They compared
RAV1 and At1g16640 structures with EcoRII-N and suggested
that the B3 family proteins bind DNA in a similar fashion,
which is perpendicular to the orientation proposed for the
model of the RAV1-B3 DNA complex by Yamasaki et al. (9).
More recently, Yamasaki et al. (32) performedmodeling exper-
iments that altered the helical axis of the DNA in their original
model by 90°. Our study of the structure and DNA binding
properties of VRN1 provides further evidence to support the
DNA-binding models of both groups (30, 32).
EcoRII-N and RAV1 are reported to bind DNA in a
sequence-specific manner, whereas VRN1 binds DNA in a
sequence-nonspecific manner. This may be explained by the
observation that RAV1 possesses two loops in positions similar
to those in EcoRII that make intimate contact with the EcoRII
recognition sequence within the DNA major groove, whereas
VRN1has only one such loop (Fig. 7). It appears that VRN1may
bind DNA in a manner that is mostly dependent on interaction
with the phosphate groups of theDNAbackbone. Golovenko et
al. (30) reported that three EcoRII residues involved in binding
the DNA phosphate backbone are conserved in RAV1 and
At1g16640. We found that two of these residues are also con-
served in VRN1: EcoRII Arg-81 (VRN1 Arg-289) and EcoRII
Thr-100 (VRN1 Ser-300). However, EcoRII Lys-23 appears to
be replaced byVal-246 in VRN1.When the crystal structures of
VRN1 and EcoRII are aligned, a number of residues that make
contacts with bases or phosphate groups in the EcoRII-DNA
complex are structurally conserved in VRN1; these include
EcoRII Arg-98/VRN1 Lys-298, EcoRII Tyr-85/VRN1 Tyr-292,
EcoRII Tyr-41/VRN1 Tyr-260, EcoRII Arg-81/VRN1 Arg-289,
and EcoRII Thr-100/VRN1 Ser-300.
The At1g16640 B3 domain was reported not to bind DNA
(10). This lack of DNA binding could be explained by the more
acidic surface of At1g16640 compared with RAV1 and VRN1.
Curiously, like VRN1, At1g16640 has only one of the two loops
of RAV1 and EcoRII. We replaced the loop of VRN1 (RPSY-
LYRGCI, VRN1(249–258)) with that of At1g16640 (ISEKSSKS,
FIGURE 6. VRN1(208–341)-DNA interaction. A, VRN1(208–341) in the same orientation as Fig. 3A and Fig. 5A displaying its electrostatic surface andmarked
with the residues most sensitive to NMR. The side chains of all residues in intermediate exchange at 0.2 M eq are shown in stick format, and those of the most
sensitive residues in intermediate exchange at 0.1 M eq of DNA are also labeled textually. The figure with a slight rotation in supplemental Fig. S3 is better to
show the “sidedness” of the DNA interaction. B, the side chains of VRN1(208–341) residuesmutated preceding DNA binding studies are shown in stick format.
C, the structureof VRN1(208–341)was superimposedonto the structureof EcoRII from the crystal structureof the EcoRII-DNAcomplex (ProteinDataBank code
3HQF) (30) using SSM in Coot. The structure of EcoRII was then removed, leaving this VRN1(208–341)-DNA overlay. No further manipulation was performed.
PyMOLwas used to produce the electrostatic surface of VRN1(208–341). The positions of three Arg residues (R249, R289, and R296) that, whenmutated toGlu,
abolished DNA binding are shown.
TABLE 2
Estimated DNA-binding Kd values for VRN1(208–341) andmutants
Todemonstrate accurate protein quantification, an equal loading of proteinwas run
on an SDS-polyacrylamide gel and Coomassie Blue-stained (supplemental Fig. S7).
Protein Kd
Kd
-fold decrease
nM
WT 10.3	 1.1 1.0
Y254A 9.1	 1.2 0.9
Y260A 13.1	 1.0 1.3
L291A 13.2	 1.2 1.3
R289A 18.8	 1.8 1.8
G295E 25.5	 2.4 2.5
Loop 26.5	 1.4 2.6
R289E 36.4	 4.9 3.5
R249A 37.1	 2.4 3.6
R296A 40.7	 3.5 4.0
R249E 86.3	 5.0 8.4
R289A/R296A 102.4	 8.0 9.9
R296E 121.9	 8.0 11.8
R289E/R296E 533.9	 44.1 51.8
R249E/R296E 601.2	 112.7 58.4
R249E/R289E 604.1	 105.3 58.7
R249E/R289E/R296E 1548.0	 721.5 150.3
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At1g16640(14–21)) expecting that this would abolish DNA
binding. However, we were surprised to find that DNA binding
by this loop substitution mutant (loop) was only slightly
reduced (2.6-fold change in Kd) (Table 2).
When first characterized, VRN1 was thought not to bind
DNA based on initial electrophoretic mobility shift assays con-
taining poly(dI-dC) (a nonspecific DNA-binding competitor).
Only when the VRN1 protein concentration was increased or
poly(dI-dC) was removed was DNA binding apparent. Surface
plasmon resonance, which does not include a nonspecific
DNA-binding competitor, confirmed the strong sequence-
nonspecific DNA binding of VRN1 (1). Given the structural
similarity between VRN1 B3b and At1g16640, it may be worth
reinvestigating its DNA binding ability using these approaches.
Our mutagenesis experiments demonstrated that to disrupt
DNA binding in the VRN1 B3b domain, charge reversal muta-
tionswere required (Arg toGlu). To completely abolish binding
required three such charge reversal mutations. These findings
suggest that the DNA-binding surface of VRN1(208–341) is
large and involves potentially dozens of residues or that the
binding surface is large but that there may be redundancy, so
when one residue or region is removed, another can compen-
sate. On the basis of our VRN1 structure, its comparison with
Protein Data Bank structures of restriction enzyme-DNA com-
plexes, and the effect of mutations on DNA binding, we have
proposed a model for the binding of DNA by VRN1(208–341).
This model could potentially explain how other B3 domains
interact with dsDNA and provides a basis for future structure-
function studies with Arabidopsis VRN1.
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SUPPLEMENTAL FIGURE LEGENDS 
SUPPLEMENTAL FIG. S1. Sequence alignment of the ten most similar proteins to VRN1 as 
determined by BLASTP. Domains are marked according to Arabidopsis VRN1. Details of the 11 proteins 
are as follows: Vitis vinifera, 355 aa, Accession: CBI32503.3, GI: 297741372; Vitis vinifera, 407 aa, 
Accession: XP_002281517.1, GI: 225428645; Populus trichocarpa, 321 aa, Accession: 
XP_002330309.1, GI: 224123414; Brassica rapa, 329 aa, Accession: AAR92199.1, GI: 40806799; 
Brassica rapa, 329 aa Accession: AAQ55453.1 ,GI: 33943517; Arabidopsis thaliana, 341 aa, Accession: 
NP_188529.2, GI: 30685150; Arabidopsis lyrata, 341 aa, Accession: XP_002885287.1, GI: 297834810; 
Thellungiella halophila, 341 aa, Accession: BAJ34355.1, GI: 312282979; Ricinus communis, 333 aa, 
Accession: XP_002519145.1, GI: 255556221; Populus trichocarpa, 341 aa, Accession: 
XP_002315168.1, GI: 224109350; Populus trichocarpa, 407 aa, Accession: XP_002330307.1, GI: 
224123406. Below the alignment is the data used to manually generate the chart in Fig. 1B. The number 
represents the similarity to Arabidopsis VRN1 (red) of the ten most similar proteins with X (=10) the 
highest possible and 0 the lowest. Identical residues were counted as 1, conserved residues as 0.5 and the 
number rounded down to the nearest unit. 
SUPPLEMENTAL FIG. S2. A modeled structure of B3a. A. Structural alignment of VRN1 B3a and 
VRN1208-341 containing the B3b domain, the model for VRN1 B3a was generated using I-TASSER. B. 
Electrostatic surfaces of the two domains in the same orientation as in panel A. C. Electrostatic surfaces 
of the three domains rotated 180o around the vertical axis relative to the surface in panel B. The structures 
were aligned in PyMOL (32). 
SUPPLEMENTAL FIG. S3. DNA binding in NMR. A. HQSC spectrum of VRN1208-341 (black) overlaid 
with HSQC spectra of VRN1208-341 after addition of either 0.1 (blue) or 0.2 (red) molar equivalents of an 
18 bp dsDNA probe. Those residues most sensitive to DNA addition are marked and labeled with blue 
text (i.e. in intermediate exchange by 0.1 molar equivalents of DNA). Residues in intermediate exchange 
only after addition of 0.2 molar equivalents of DNA are marked and labeled with red text. Residues 
unchanged by addition of 0.1 or 0.2 molar equivalents of DNA are left unmarked. B. VRN1208-341 in an 
orientation slightly rotated from those shown in Fig. 3a and Fig. 5a to better to show the ‘sided-ness’ of 
the DNA interaction. The cartoon model is shown below the electrostatic surface and is marked with the 
residues most sensitive to NMR. The side chains of all residues in intermediate exchange at 0.2 molar 
equivalents are shown in stick (green) format, those most sensitive residues in intermediate exchange by 
0.1 molar equivalents of DNA are also labeled textually. 
SUPPLEMENTAL FIG. S4. Monitoring the effect of the R249A, Y254A, Y260A, R289A, L291A and 
R296A single mutations on the fold of VRN1208-341. An HSQC spectrum was acquired for each protein 
(red) and overlaid on a wild type protein spectrum (black). Changes to the chemical shift of residues that 
revealed the underlying wild type peak are labeled. To the right of each HSQC overlay are ribbon models 
of VRN1208-341 with the B3 domain in navy blue and the conserved region in gray. The residue(s) changed 
in each protein mutant is marked in red with its side chain displayed in stick format. For residues that 
changed in chemical shift so as to be labeled in the HSQC, these residues are colored green and their side 
chains also shown in stick format. 
SUPPLEMENTAL FIG. S5. Monitoring the effect of the R289E, double R289A R296A, R296E, 
G295E, loop change (loop) and double R289E R296E mutations on the fold of VRN1208-341. Details as 
Supplemental Fig. S4. 
SUPPLEMENTAL FIG. S6. Monitoring the effect of the R249E, double R249E R296E, triple R249E 
R289E R296E and double R249E R289E mutations on the fold of VRN1208-341. Details as Supplemental 
Fig. S4. 
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SUPPLEMENTAL FIG. S7. SDS-PAGE gel of VRN1208-341 protein and its mutants to demonstrate 
accurate A280 quantification, 2 µg of each protein was loaded on a NUPAGE 4-12% Bis-Tris gel 
(Invitrogen) and run according to manufacturer’s specifications. 
 
CBI32503.3 MPEQETLDHSHCRRPSSQPTRSLLFYKLIVSSVLQAKRLRIPQKFVKKSGDQLSAVTTLTLPNGGVWYVGLTKADN--KFWFYHGWHEFVEYYSIHVGYFLIFRYEGNSNFNVNIFDLTASEINYPSN
XP_002281517 MPEQETLDHSHCRRPSSQPTRSLLFYKLIVSSVLQAKRLRIPQKFVKKSGDQLSAVTTLTLPNGGVWYVGLTKADN--KFWFYHGWHEFVEYYSIHVGYFLIFRYEGNSNFNVNIFDLTASEINYPSN
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XP_002330309 SLSQLQESSHDNPCLLP-----NEKDDGLEKLT--------------STEDG-AG--SVIPGITRKTRGRKRMSENIEDVDKHASPGIQNVKLKSTHVRNTSETLTR---------RRRAVTPEEKER
AAR92199.1 GLMDSASHNNHFKRPRLFEDLEDEDAETLHTT-------------------A-SAIQSFFTGPVKPEEATPTQTSKVPKKRGRKKKNADHPEEVNSSAPRDDDPESRSKFYESASARKRTVNAEERER
AAQ55453.1 GLMDSASHNNHFKRPRLFEDLEDEDAETLHTT-------------------A-SAIQSFFTGPVKPEEATPTQTSKVPKKRGRKKKNADHPEEVNSSAPRDDDPESRSKFYESASARKGTVNAEERER
NP_188529.2 GLMDSAHN--HFKRARLFEDLEDEDAEVIFPSSVYPSPLPESTVPANKGYAS-SAIQTLFTGPVKAEEPTP--TPKIPKKRGRKKKNAD-PEEINSSAPRDDDPENRSKFYESASARKRTVTAEERER
XP_002885287 GLMDSAHN--HFKRARLFEDLEDEDAEFIFPSSVYPSPLPESTVPANKGYAG-SAIQSLFTGSVKAEEATP--TPKIPKKRGRKKKNAD-PEEINSSAPRDDDPENRSKFYESASARKRTVTAEERER
BAJ34355.1 GLMDSAHN--HFKRARLFEDLEDEDAEVIYPSSVYPSPLPDSTVPANKGYSG-SAIQSLFTGPVKAEEATP--TPKVPKKRGRKKKNAD-PEEINSSAPRDDDPENRSKFYESASARKRTVTAEERER
XP_002519145 NTAG--------RRYLLFEDMEDDDFVEHLSS-------------------S-SPCLVPNSLKSDVRYYTPDAEAQKPKKRGRKKLKVD-PNQQQPSAQQEDEVDMRFRFYESASARKRTVTAEERER
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AAR92199.1 AVNAAKTFEPTNPFFRVVLRPSYLYRGCIMYLPSGFAEKYLSGISGFIKVQLGE-KQWPVRCLY-KAGRAKFSQGWYEFTVENNLGEGDVCVFELLRTRDFVLKVTAYRVNEYV
AAQ55453.1 AVNAAKTFEPTNPFFRVVLRPSYLYRGCIMYLPSGFAEKYLSGISGFIKVQLGE-KQWPVRCLY-KAGRAKFSQGWYEFTVENNLGEGDVCVFELLRTRDFVLKVTAYRVNEYV
NP_188529.2 AINAAKTFEPTNPFFRVVLRPSYLYRGCIMYLPSGFAEKYLSGISGFIKVQLAE-KQWPVRCLY-KAGRAKFSQGWYEFTLENNLGEGDVCVFELLRTRDFVLKVTAFRVNEYV
XP_002885287. AINAAKTFEPTNPFFRVVLRPSYLYRGCIMYLPSGFAEKYLSGISGFIKVQLAE-KQWPVRCLY-KAGRAKFSQGWYEFTLENNLGEGDVCVFELLRTRDFVLKVTAFRVNEYV
BAJ34355.1 AINAAKTFEPTNPFFRVVLRPSYLYRGCIMYLPSGFAEKYLSGISGFIKVQLAE-KQWPVRCLY-KAGRAKFSQGWYEFTLENNLGEGDVCVFELLRTRDFVLKVTAFRVNEYV
XP_002519145 AINTAKTFEPMNPFCRVVLRPSYLYRGCIMYLPSCFAEKHLNGVSGFIKLQSSDGKQWPVRCLY-RGGRAKLSQGWYEFTLENNMGEGDVCVFELLKSRDIVLKVTVFRVLEGAGRMTQTLTTKYEQR
XP_002315168 AIHAARMFKPKSPSFMVMLR-RYNFYNHFLYVPLEFAQRHLSDAPRCIKLQVSDGREWPIQINRNQCRYLSISKGWNEFSQENNLKEGDVCVFELINKEKFVLKVAIFHELEDNVPSD
XP_002330307 AIHAARMFRPKNPSFMVLLR-SYN--KCFVAVPAEFSKRHLSGVSEHIKLQVSDGRQWPLRLNKTQRARMIISRGWNEFKRENNLKEGDVCVFELIKNKKFSLQVSMFRAVDGSGPSN
Number. 9859X65X5959X878X7XX69X666666767X84X9786X686868997X537099X8998750546868496XX5XX549XX95XXXXX9XXX7545769X9X67998484500000000000000
B3a
B3b
PEST1 PEST2 NLS

11 10 9 8 7 6
130
125
120
115
110
0.2 DNA
0.1 DNA
A217
Y260
R220
W303Nε
E305
L291
R289
L253
Y254
M259
I258S300
K298,S214
G315
G302
N338
G256
T223
V337
F299
R218
V222
A233
K219
E213,L261
E314,T221
no DNA
L291
R289
Y260
Y254
V222
A233
R249A
Y254A
Y260A
R289A
L291A
R296A
G295K293
L291
Y292
Y260
A266F299
A297
E267
G256
R296
M259
K298
S300
S300
I258
S271
C290
G295K293
L291
Y292
Y260
A266A297
W303
F299
G302
R296
K278
K298
S271
G275 G272
R289
C290
G295
G295
K293
L291
Y292
Y260
L323
V288
A266
W303
F276
E267
G302
F306
K278
M259
K298
L270
S300
S271
G275 G272
R289
K293
L291
Y292
Y260
A266
S274
F299
A297
W303
F276
G302
R296
K278
E309
M259
K298
S300 I258
G275
G272
L308
V341
R249
R220
W303
R255
A233
F335
E305
L248
V337
T223
E314,T221
Y304
E225
N338
G302
G256
F306
L253N311
C257
S300
I258
Y254
T307
G313
V247
Y260
R249
F299
L248
Y252
M259
L253
G315
W303N
W303N
W303N
R289E
R289A R296A
R296E
G295E
loop
R289E R296E
G295
R289
V288
C290
L291
Y292
Y260,A215
W303
M259
K278
F276
F299
S274
V279
L330
G302
G256
F306
S300
G275
I258
L270
K298,S214
K298,S214
Y254
G295
R289
C290
L291
K293
Y260,A215
F276
A297
A266
L330
S300
G275
G272
G272
R296
G295
L291
K293
A297
Y292
Y260,A215
M259F299
A266
I258
R296
G295
L291
K293
L323
A217
Y292
Y260,A215
E213,L261 F265,I273
K278
F276 F299
S274
A297
A266
F211
Y304
E267
S300
I258
K298,S214
R296
G272
S271
L308
A234
Y212
L312
F211
F237
V341
F265,I273
A230
R249
G295
R289
Q280
W303N
V288
L322
F320
V319
C290 E238
K298,S214
K293
K293
V222
A217
L281
L291 L323
Y292
Y260,A215
R220
M259
K278
F335
L248
K331
W286
E305
V337
V317
R245
I277
F276
F299
S274
V279 A297
A297
L330
A224
T223
Y304
E225
N338
G302
G256
E267
F306
N241
C257 I231
S300
G315
F244
I258
L270F243
Y254
K268
T307
G272
T236
N310
S271
G313
T240
G295
R289
V288
C290
L291
Y292
Y260,A215
W303
M259
K278
F299
S274
A266
L330
G302 S300
G275
I258
L270
Y254
R296
S271
K298,S214
R249E
R249E R296E
R249E R289E R296E
R249E R289E
R249
I231
G315
T236
A233
E226
Y340
V222
R336
N338
T223
R245
V337
Y252
V247
L248
K298,S214
F237
V341
F265,I273
R249
I231
M259
K278
A234
G315
G275
G302
T236
A233
E226
V222
N338
E267
T223
E225
R245
V337
E305
Y252
L270
E228
V247
C290
L323
L248
G295
L291
Y292
K293
R289
V288
L322
L330
R336
W303
F276
A297
A266
E314,T221
F299
S274
S300 I258
G272
R296
Y254
S271
Y260,A215
K298,S214
F237
V341
R249
I231
M259
K278
A234
G315
T236
A233
E226
V222
N338
E267
T223
E225
R245
Y252
E228
V247
C290
L248
G295
L291
Y292
K293
F276
A297
A266
E314,T221
F299
S300 I258
G272
R296
Y260,A215
Y340
K298,S214
R249
I231
M259
K278
G315
G275
G302
T236
A233
E226
V222
N338
T223
V337
E305
V246
L270
V247
C290
L323
L248
G295
L291
Y292
R289
V288
L322
L330
R336
W303
F276
F299
Y304
S274
S300
G256 I258
R296
S271
Y260,A215
Y340

Byriel, Justine M. Hill, Jennifer L. Martin and Joshua S. Mylne
Gordon J. King, Aurélie H. Chanson, Emily J. McCallum, Masaru Ohme-Takagi, Karl
Revealing Its DNA-binding Surface
Processes Essential for Development, with Structural and Mutational Studies 
 B3 Domain Protein VERNALIZATION1 (VRN1) Is Involved inArabidopsisThe 
doi: 10.1074/jbc.M112.438572 originally published online December 19, 2012
2013, 288:3198-3207.J. Biol. Chem. 
  
 10.1074/jbc.M112.438572Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
Supplemental material:
  
 http://www.jbc.org/content/suppl/2012/12/19/M112.438572.DC1.html
  
 http://www.jbc.org/content/288/5/3198.full.html#ref-list-1
This article cites 31 references, 12 of which can be accessed free at
 at UQ Library on September 1, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
